Text to be removed highlighted in red.
156:1 Short Title. This act shall be known as the lead poisoning prevention and treatment act of 2024.
156:2 Accident and Health Insurance. Amend RSA 415:6-v to read as follows:
415:6-v Coverage for Blood Lead Testing. Each insurer that issues or renews any individual policy, plan, or contract of accident or health insurance providing benefits for medical or hospital expenses shall provide to persons covered by such insurance who are residents of this state coverage for the costs of blood lead testing conducted pursuant to RSA 130-A:5-a. Benefits provided under this section shall not be subject to any greater co-payment, deductible, or coinsurance than any other similar benefits provided by the insurer.
156:3 Accident and Health Insurance. Amend RSA 415:18-aa to read as follows:
415:18-aa Coverage for Blood Lead Testing. Each insurer that issues or renews any policy of group or blanket accident or health insurance providing benefits for medical or hospital expenses shall provide to each group, or to the portion of each group comprised of certificate holders of such insurance who are residents of this state, coverage for the costs of blood lead testing conducted pursuant to RSA 130-A:5-a. Benefits provided under this section shall not be subject to any greater co-payment, deductible, or coinsurance than any other similar benefits provided by the insurer.
156:4 Effective Date. This act shall take effect 60 days after its passage.
Approved: July 03, 2024
Effective Date: September 01, 2024
Text to be added highlighted in green.
156:1 Short Title. This act shall be known as the lead poisoning prevention and treatment act of 2024.
156:2 Accident and Health Insurance. Amend RSA 415:6-v to read as follows:
415:6-v Coverage for Blood Lead Testing. Each insurer that issues or renews any individual policy, plan, or contract of accident or health insurance providing benefits for medical or hospital expenses shall provide to persons covered by such insurance who are residents of this state coverage for the costs of blood lead testing conducted pursuant to RSA 130-A:5-a. Benefits provided under this section shall not be subject to any co-payment, deductible, or coinsurance . Benefits provided under this section shall include any follow-up blood lead testing that is necessary to complete the preventive screening when the initial blood lead testing indicates an elevated blood lead level or is inconclusive.
156:3 Accident and Health Insurance. Amend RSA 415:18-aa to read as follows:
415:18-aa Coverage for Blood Lead Testing. Each insurer that issues or renews any policy of group or blanket accident or health insurance providing benefits for medical or hospital expenses shall provide to each group, or to the portion of each group comprised of certificate holders of such insurance who are residents of this state, coverage for the costs of blood lead testing conducted pursuant to RSA 130-A:5-a. Benefits provided under this section shall not be subject to any co-payment, deductible, or coinsurance . Benefits provided under this section shall include any follow-up blood lead testing that is necessary to complete the preventive screening when the initial blood lead testing indicates an elevated blood lead level or is inconclusive.
156:4 Effective Date. This act shall take effect 60 days after its passage.
Approved: July 03, 2024
Effective Date: September 01, 2024